695 related articles for article (PubMed ID: 26084935)
1. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
2. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
4. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire.
Jurecki E; Cunningham A; Birardi V; Gagol G; Acquadro C
Health Qual Life Outcomes; 2017 Mar; 15(1):46. PubMed ID: 28274259
[TBL] [Abstract][Full Text] [Related]
5. Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire.
Barta AG; Sumánszki C; Turgonyi Z; Kiss E; Simon E; Serfőző C; Reismann P
Mol Genet Metab Rep; 2020 Jun; 23():100589. PubMed ID: 32346514
[TBL] [Abstract][Full Text] [Related]
6. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial functioning in children with phenylketonuria: Relationships between quality of life and parenting indicators.
Morawska A; Mitchell AE; Etel E; Kirby G; McGill J; Coman D; Inwood A
Child Care Health Dev; 2020 Jan; 46(1):56-65. PubMed ID: 31782540
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.
Cazzorla C; Cegolon L; Burlina AP; Celato A; Massa P; Giordano L; Polo G; Daniele A; Salvatore F; Burlina AB
BMC Public Health; 2014 Dec; 14():1243. PubMed ID: 25471331
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
11. The impact of phenylketonuria on PKU patients' quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires.
Alptekin IM; Koc N; Gunduz M; Cakiroglu FP
Clin Nutr ESPEN; 2018 Oct; 27():79-85. PubMed ID: 30144897
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in a european sample of adults with early-treated classical PKU.
Maissen-Abgottspon S; Muri R; Hochuli M; Reismann P; Barta AG; Alptekin IM; Hermida-Ameijeiras Á; Burlina AP; Burlina AB; Cazzorla C; Carretta J; Trepp R; Everts R
Orphanet J Rare Dis; 2023 Sep; 18(1):300. PubMed ID: 37740225
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.
Ziesch B; Weigel J; Thiele A; Mütze U; Rohde C; Ceglarek U; Thiery J; Kiess W; Beblo S
J Inherit Metab Dis; 2012 Nov; 35(6):983-92. PubMed ID: 22391997
[TBL] [Abstract][Full Text] [Related]
14. Sapropterin treatment does not enhance the health-related quality of life of patients with phenylketonuria and their parents.
Feldmann R; Wolfgart E; Weglage J; Rutsch F
Acta Paediatr; 2017 Jun; 106(6):953-959. PubMed ID: 28235150
[TBL] [Abstract][Full Text] [Related]
15. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in children living with PKU - a single-center, cross-sectional, observational study from Hungary.
Becsei D; Hiripi R; Kiss E; Szatmári I; Arató A; Reusz G; Szabó AJ; Bókay J; Zsidegh P
Mol Genet Metab Rep; 2021 Dec; 29():100823. PubMed ID: 34900594
[TBL] [Abstract][Full Text] [Related]
17. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
[TBL] [Abstract][Full Text] [Related]
18. The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria.
Burlina AP; Cazzorla C; Massa P; Loro C; Gueraldi D; Burlina AB
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32674279
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride.
Douglas TD; Ramakrishnan U; Kable JA; Singh RH
Health Qual Life Outcomes; 2013 Dec; 11():218. PubMed ID: 24373161
[TBL] [Abstract][Full Text] [Related]
20. Adherence to diet and quality of life in patients with phenylketonuria.
Cotugno G; Nicolò R; Cappelletti S; Goffredo BM; Dionisi Vici C; Di Ciommo V
Acta Paediatr; 2011 Aug; 100(8):1144-9. PubMed ID: 21342250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
